Exploration of the new classification of hormone receptor-positive breast cancer: Based on the genomic landscape of 2111 early to mid-stage Asian patients. Long-term outcomes in triple-negative breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results